A bill to amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.
119th Congress
Requires drug labels to display original manufacturer and full supply chain details, improving transparency for consumers and providers.
Introduced in Senate
